STUDYING OF ACUTE TOXICITY AND ANTI-INFLAMMATORY ACTIVITY OF PULSATILA ALBA ETHANOLIC EXTRACTS
DOI:
https://doi.org/10.11603/2312-0967.2019.2.10189Keywords:
Pulsatila alba, acute toxicity, anti-inflammatory activity, carrageenan oedemaAbstract
The aim of the work. Research of the acute toxicity and anti-inflammatory (anti-exudative) activity studying of Pulsatila alba ethanolic extracts.
Materials and Methods. Acute toxicity studies were performed on 60 white rats of both sexes weighing 190–220 g, which were administered intragastric single-dose of tested extracts at doses of 5000, 10,000 and 15,000 mg/kg. The carragenine model of inflammatory oedema of white rats paw was used for anti-exudative activity studying. The tested extracts were administered intragastrically at a dose of 2 ml/kg. Diclofenac sodium and ketanov were used as reference drugs.
Results and Discussion. The results of Pulsatila alba ethanolic extracts acute toxicity studying demonstrated absence of any toxic manifestations in intragastric administration at doses of 5000, 10,000 and 15,000 mg/kg in white rats, which allows their to VI class of toxicity (relatively harmless substances). The Pulsatila alba ethanolic extracts posses a tendency for anti-inflammatory activity in the carrageenan model of inflammatory edema in white rats and the pharmacological effect depends on the concentration of ethanol and the ratio of raw material: extractant. The best anti-exudative activity was detected for 70 % ethanolic extracts (1:20), an inhibition index of inflammatory response was 27 %, which is slightly inferior to reference drugs (by 10 and 17 % relative ketanov and sodium diclofenac, respectively) and is a good level for anti-inflammatory phitopreparations.
Conclusions. The acute toxicity and anti-inflammatory effect of Pulsatila alba ethanolic extracts were investigated and it was established that 70 % alcoholic extract (1:20) is a relatively harmless substance (grade VI toxicity) and has potency anti-inflammatory activity (inhibition of inflammation - 27 %) on the carrageenan model of inflammatory edema of the white rat paws at intragastric administration.
References
Maione F, Russo R, Khan H, Mascolo N. Medicinal plants with anti-inflammatory activities. Nat. Prod. Res. 2016;30(12): 1343-52. doi:10.1080/14786419.2015.1062761. DOI: https://doi.org/10.1080/14786419.2015.1062761
Hudzenko АV, Curkan OO, Kovalchuk TV. [Domestic market of multicomponent herbal medicinal products: analysis of the state of the structure and development prospects]. Farmats zhurn., 2012;1: 8-12. [Ukrainian].
Cao P, Wu FE, Ding LS. Advances in the studies on the chemical constituents and biologic activities for Anemone species. Nat Prod Res Dev. 2004;16: 581-4. doi:10.3969/j.issn.1001-6880.2004.06.024
Zou ZJ, Liu HX, Yang JS. Phytochemical components and pharmacological activities of the genus Anemone. Chin Pharm J. 2004;39: 493-5.
Lukianchuk А, Khropot О, Konechnyi Yu, Konechna R, Novikov V. Anemone nemorosa L. Analytical review. ScienceRise: Pharm. Sci. 2017;3(7): 38-42. doi:10.15587/2519-4852.2017.104438 Ukrainian. DOI: https://doi.org/10.15587/2519-4852.2017.104438
Agrawal T. Anemone Pulsatilla a useful drug plant. Biomed J Sci Tech Res. 2018;8(3): 1-2. doi:10.26717/BJSTR.2018.08.001658 DOI: https://doi.org/10.26717/BJSTR.2018.08.001658
Konechna R, Khropot O, Kurka M, Petrina R, Gubriy Z, Novikov V. Research of antioxidant properties of extracts of the plants and the callus biomass. Asian J Pharm Clin Res. 2017;10(7): 182-5. doi:10.22159/ajpcr.2017.v10i7.18408 DOI: https://doi.org/10.22159/ajpcr.2017.v10i7.18408
European convention for the protection of vertebrate animals used for experimental and other scientific purpose. - Strasburg, Council of Europe, Publication and Documents Division. Printed in France. Edition November; 1987.
[Ethics of a doctor and human rights: provisions on the use of animals in biomedical experiments]. Eksperyment i klin fiz i biokhim. 2003;2(22): 108-9. in Ukrainian.
Litchfield JT, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther. 1949;96: 99
Stefanov OV. (Ed). Preclinical studies of drugs: guidelines. [Доклінічні дослідження лікарських засобів: метод. рек.] Kyiv: 2001. Ukrainian.
Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Proc Soc Exp Biol Med. 2016;111(3): 544-7. DOI: https://doi.org/10.3181/00379727-111-27849
Sidorov KK. Classification of the toxicity of poisons in the parenteral method of administration [О класификации токсичности ядов при парэнтеральном способе введения] Moscow: Meditsina; 1973. Russian.
Downloads
Published
How to Cite
Issue
Section
License
The authors who publish their materials in this journal agree with the following terms:
- Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal .
- Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.
Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).